As of April 16, 2025, Trevi Therapeutics (TRVI) has a market cap of $0.60 billion USD. According to our data, Trevi Therapeutics is ranked No.5738 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.60 B |
62.81%
|
Dec 31, 2024 | $0.37 B |
207.46%
|
Dec 29, 2023 | $0.12 B |
-30.57%
|
Dec 30, 2022 | $0.17 B |
146.80%
|
Dec 31, 2021 | $69.88 M |
-67.69%
|
Dec 31, 2020 | $0.22 B |
-35.47%
|
Dec 31, 2019 | $0.34 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Cara Therapeutics
CARA
|
$24.33 M |
0.000 M
|
![]() USA
|
![]() Intra-Cellular Therapies
ITCI
|
$14.05 B |
0.000 M
|
![]() USA
|
![]() Corbus Pharmaceuticals
CRBP
|
$73.27 M |
-0.000 M
|
![]() USA
|
![]() Pacira Biosciences
PCRX
|
$1.15 B |
-0.000 M
|
![]() USA
|
![]() Heron Therapeutics
HRTX
|
$0.29 B |
0.000 M
|
![]() USA
|
![]() Collegium Pharmaceutical
COLL
|
$0.87 B |
0.000 M
|
![]() USA
|
![]() Assertio Therapeutics
ASRT
|
$60.28 M |
-0.000 M
|
![]() USA
|
![]() Nektar Therapeutics
NKTR
|
$0.12 B |
0.000 M
|
![]() USA
|
![]() Supernus Pharmaceuticals
SUPN
|
$1.76 B |
-0.000 M
|
![]() USA
|
![]() Alkermes
ALKS
|
$4.61 B |
-0.000 M
|
![]() Ireland
|
Market Cap | = | TRVI Stock Price | * | TRVI Shares Outstanding |
= | $6.20 | * | 96.68 M | |
= | $0.60 B |